Genethon Lecture Series: 2018, March 21th

  • Wednesday March 21th, 2018:

«Recombinant AAV for Human Gene Therapy: Progress, Challenges and Perspectives for Vector Design, Manufacturing and Characterization»

Pr Fraser Wright, Co-Founder and Chief Technology Advisor / Officer at Spark Therapeutics, former Scientific Director, Clinical Vector Core at the University of Pennsylvania and former Director of Development and Manufacturing at Avigen.15